Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q38262767

about

Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregation.The diabetic brain and cognition.Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment.Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure-Activity Relationship.Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents.A strategy to find novel candidate anti-Alzheimer's disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants.

P2860

Q38668998-2FC35F61-95B8-441A-9AD5-71571B2091F3 Q40098573-13DEC64C-8F89-4BD0-9D62-65979AC9E964 Q44708433-BAD772CC-BAEF-4AC6-92E2-72F6270F1D9B Q47117680-7D29CAC1-1EDF-43EC-A007-B79FA7096425 Q47937308-CCE9B04E-3DF6-47F3-B47F-E0C122980118 Q48173457-CD0375B7-7BF1-4C7D-A287-F1FD40F6BE2C Q49703452-7D3CE818-FE8E-40E4-AE8A-EFD813137556 Q52657306-AE18F8FD-D971-4056-A856-3CB499A931F2 Q53182177-6F50319C-FE38-49D9-8EC6-8C355C1008FD Q55092298-71EEFA37-44EC-4184-82A7-3CF3A4A38D26

P2860

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q38262767

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Status of acetylcholinesterase ...... and type 2 diabetes mellitus.

@en

type

label

Status of acetylcholinesterase ...... and type 2 diabetes mellitus.

@en

prefLabel

Status of acetylcholinesterase ...... and type 2 diabetes mellitus.

@en

P1433

Q38262767-A5C0D125-5D72-42F7-99C3-5F08FA310B0F

P1476

Q38262767-7F6E2597-9DB7-48B5-80C2-9A1B2B153C48

P2093

Q38262767-0B8DC510-C7FD-4A56-9F71-A18BA176D5C4

Q38262767-AC4EB5E6-4110-42D3-9113-C732B6FDF21E

Q38262767-CC2D4798-570C-478F-B55E-96A16AC2A153

P2860

Q38262767-0BE76C94-CCBA-4DC3-B8A5-9F082EDD1D35

Q38262767-0C97F960-7898-4F8E-81BA-B0CC267EC5A8

Q38262767-13605FE9-7F2F-47E0-A10C-12B5CE08B6F6

Q38262767-198EF331-E899-469F-B312-9079988FFCDE

Q38262767-2212C243-34C4-4EA3-99EC-066E01771995

Q38262767-26B1C5CB-7429-47F3-AF45-DD0C8DBCE81A

Q38262767-27D07B34-6C0B-4C5D-9E3C-5C9A4A1B153D

Q38262767-28E459F2-4BE4-43DD-A506-776763F7CED0

Q38262767-2E9EFDF4-6E07-408F-AD51-59989EA043D7

Q38262767-2FF9043E-A90C-4D6A-A0C4-C8CCA9F9B79C

P304

Q38262767-B0092A14-0101-45EB-91FD-01888A729A28

P31

Q38262767-150F2DC3-C538-413B-8DC4-B74B3632505A

P356

Q38262767-AD695BF5-1BE2-4106-9A8C-E0D5DF8FC959

P433

Q38262767-2AC54FFD-6DAA-4F7E-AD7B-C9158099D392

P478

Q38262767-CA482A57-D95C-46CA-A8AE-7B45D4686A3B

P50

Q38262767-77BB7096-3244-42B3-80C3-FAEAE27364A9

P577

Q38262767-3A1DAF21-90EC-46D7-BFC8-2EC27E47D32B

P698

Q38262767-80D683D3-7C7A-4FE2-B1DD-86C023E17007

P921

Q38262767-8490EC90-1B1B-459A-ADC2-804AF58C98E5

P932

Q38262767-B1B05781-978D-4749-92DD-A0A5C487E926

P356

1871527313666141023141545

P1433

CNS and Neurological Disorders

P1476

Status of acetylcholinesterase ...... and type 2 diabetes mellitus.

@en

P2093

Gohar Mushtaq

http://www.w3.org/2001/XMLSchema#string

Mohammad A Kamal

http://www.w3.org/2001/XMLSchema#string

Nigel H Greig

http://www.w3.org/2001/XMLSchema#string

P2860

Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.

Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs

alpha-Lipoic acid as a biological antioxidant.

Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms

The cholinergic hypothesis of geriatric memory dysfunction

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

Enzymes of the cholinergic system in islets of Langerhans

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

P304

1432-1439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1871527313666141023141545

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jalaluddin A. Khan

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25345511

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5878042

http://www.w3.org/2001/XMLSchema#string